Categories
Archives
Receive Email Updates
-
-
-
Certified Licensing Professionals, Inc., 2021 
Disclaimer
This blog, Patents4Life, does not contain legal advice and is for informational purposes only. Its publication does not create an attorney-client relationship nor is it a solicitation for business. This is the personal blog of Warren Woessner and does not reflect the views of Schwegman Lundberg & Woessner, or any of its attorneys or staff. To the best of his ability, the Author provides current and accurate information at the time of each post, however, readers should check for current information and accuracy.
-
- About Me
Warren D. Woessner
Pages
Archives
Author Archives: Warren Woessner
Former USPTO Official Drew Hirshfeld Joins Schwegman Lundberg & Woessner as Principal
We are very pleased to announce that Drew Hirshfeld will be joining SLW on June 27 as a Principal. Drew has been a long-tenured employee of the United States Patent and Trademark Office (USPTO), and was named one of Managing IP’s Top 50 Most Influential People … Continue reading
Novartis v. Accord Redux – Panel 2 Reverses Panel 1
To save me a lot of typing, please read my post of January 10, 2022, summarizing the first Panel’s holding in Novartis Pharmaceutical v Accord Healthcare, Inc., 21 F.4th 1362 (Fed. Cir., 2022). The panel in that decision was Judges … Continue reading
The Solicitor’s Holistic Approach to the Mayo/Alice Analysis in American Axle
This is not exactly breaking news, and other commentators have discussed it, but I think that the Solicitor General’s Amicus Brief urging the Supreme Court to grant cert. in American Axle v. Neapco Holdings, Appeal No. 20-891 (May 2022) contains … Continue reading
Almirall v. Amneal Pharmaceuticals – Negative Limitations II
This post gets a “Part II” designation because the Fed. Cir. clarified the support necessary to find a negative limitation in the prior art (Almirall LLC v. Amneal Pharmaceuticals LLC, Appeal No. 2020-2331 (Fed. Cir., March 14, 2022)). In my … Continue reading